Prime Medicine (PRME) Return on Sales (2024 - 2026)

Prime Medicine's (PRME) quarterly Return on Sales came in at 2.67% in Q1 2026, down 232.0% YoY from 2.02% in Q1 2025, and down 371.1% on a QoQ basis from 0.57% in Q4 2025.

Prime Medicine (PRME) Return on Sales (2024 - 2026) Analysis & Trends

Prime Medicine (PRME) has 3 years of Return on Sales data on file, last reported at 2.67% in Q1 2026.

  • Quarterly Return on Sales fell 232.0% year-over-year to 2.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.12% (down 60.0% YoY) and the FY2025 annual result came in at 0.44%, up 22.0% from the prior year.
  • Return on Sales slipped to 2.67% in Q1 2026, from 0.57% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.19% in Q4 2024 to a low of 3.68% in Q2 2024.
  • A 3-year average of 1.36% and a median of 0.77% in 2024 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2025 — Return on Sales surged 321 bps — and 2026, when it sank 232 bps.
  • Tracing PRME's Return on Sales over 3 years: stood at 0.19% in 2024, then plunged by 193 bps to 0.57% in 2025, then tumbled by 371 bps to 2.67% in 2026.
  • The last three Return on Sales figures came in at 2.67% (Q1 2026), 0.57% (Q4 2025), and 1.02% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Prime Medicine 558.48 Mn 558.48 Mn - -1.87%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.87%
Mar 31, 2026 -2.67%
Dec 31, 2025 -0.57%
Sep 30, 2025 -1.02%
Jun 30, 2025 -0.47%
Mar 31, 2025 -0.36%
Dec 31, 2024 -0.19%
Sep 30, 2024 -2.51%
Jun 30, 2024 -3.68%
Mar 31, 2024 -0.77%